Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT07632157

MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation

Conditions: Atrial Flutter With Rapid Ventricular Response

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: PHASE3

Enrollment: 196

Sponsor: Wake Forest University Health Sciences

Location: Advocate Christ Medical Center Emergency Department (ACMC ED) Oak Lawn Illinois

Summary

The purpose of this research study is to find out if the use of magnesium in addition to Metoprolol, a rate controlling medication that you would be offered in the Emergency Department today unrelated to this study, will help reduce your high heart rate (rapid ventricular response).

Eligibility Criteria

Inclusion Criteria: * Age \> 18 years or older * Able to provide informed consent * Primary diagnosis atrial fibrillation or atrial flutter with rapid ventricular response (AFF RVR) greater than or equal to 120 beats per minute * Metoprolol as rate control agent * English speaking Exclusion Criteria: * Hemodynamically unstable patients (SBP \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07632157). StuddyBuddy aggregates publicly available trial information.